drugset / Trial / NCT00446940

Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C

NCT00446940

Phase 2 Completed 16 enrolled Bader, Ted, M.D.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Different Doses of rosuvastatin and atorvastatin will be used to see if HCV viral load changes and liver tests change.

Timeline

Start
2006-12
Primary completion
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule
Subject Rosuvastatin Small molecule